Publikationen, an denen er mitarbeitet Rafael Cantón Moreno (10)

2022

  1. Imitation of β-lactam binding enables broad-spectrum metallo-β-lactamase inhibitors

    Nature Chemistry, Vol. 14, Núm. 1, pp. 15-24

2018

  1. Emergence of ESBL-producing Escherichia coli ST131-C1-M27 clade colonizing patients in Europe

    Journal of Antimicrobial Chemotherapy, Vol. 73, Núm. 11, pp. 2973-2980

2015

  1. CTX-M-15-non-ST131 Escherichia coli isolates are mainly responsible of faecal carriage with ESBL-producing Enterobacteriaceae in travellers, immigrants and those visiting friends and relatives

    Clinical Microbiology and Infection, Vol. 21, Núm. 3, pp. 252.e1-252.e4

2014

  1. Erratum: Recombination blurs phylogenetic groups routine assignment in escherichia coli: Setting the record straight (PLoS ONE (2014) 9:8 (e105395) DOI: 10.1371/journal.pone.0105395)

    PLoS ONE

  2. Recombination blurs phylogenetic groups routine assignment in Escherichia coli: Setting the record straight

    PLoS ONE, Vol. 9, Núm. 8

2013

  1. Normal Mutation Rate Variants Arise in a Mutator (Mut S) Escherichia coli Population

    PLoS ONE, Vol. 8, Núm. 9

2011

  1. In vitro selection of variants resistant to β-lactams plus β-lactamase inhibitors in CTX-M β-lactamases: Predicting the in vivo scenario?

    Antimicrobial Agents and Chemotherapy, Vol. 55, Núm. 10, pp. 4530-4536

  2. Stationary biofilm growth normalizes mutation frequencies and mutant prevention concentrations in Pseudomonas aeruginosa from cystic fibrosis patients

    Clinical Microbiology and Infection, Vol. 17, Núm. 5, pp. 704-711

2010

  1. Polymorphic mutation frequencies of clinical and environmental Stenotrophomonas maltophilia populations

    Applied and Environmental Microbiology, Vol. 76, Núm. 6, pp. 1746-1758

2005

  1. Increased mutation frequencies in Escherichia coli isolates harboring extended-spectrum β-lactamases

    Antimicrobial Agents and Chemotherapy, Vol. 49, Núm. 11, pp. 4754-4756